INSYS Therapeutics, Inc.

0.29000-1.36%Vol 11.37M1Y Perf -96.25%
Jun 18th, 2019 20:01 DELAYED
BID0.00 ASK0.00
Open0.2700 Previous Close0.3000
Pre-Market- After-Market-
 - -%  - -%
Target Price
6.00 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap21.63M 
Earnings Rating
Neutral
Price Range Ratio 52W %
0.00 
Earnings Date
14th May 2019

Today's Price Range

0.25000.3800

52W Range

0.140011.65

Summary:

Technical Indicators:
Moving Averages:
Performance
1 Week
-
1 Month
-
3 Months
-
6 Months
-
1 Year
-96.25%
3 Years
-97.78%
5 Years
-99.21%
10 Years
-95.81%

TickerPriceChg.Chg.%
INSY0.29000.0000-1.36
AAPL378.104.25001.14
GOOG1 513.4917.79001.19
MSFT213.162.46001.17
XOM43.72-0.6700-1.51
WFC24.71-0.7800-3.06
JNJ143.280.30000.21
FB247.196.91002.88
GE6.79-0.2100-3.00
JPM92.59-2.4100-2.54
Earnings HistoryEstimateReportedSurprise %
Q01 2019--0.58-
Q04 2018-0.33-0.39-18.18
Q03 2018-0.32-0.40-25.00
Q02 2018-0.25-0.37-48.00
Q01 2018-0.24-0.228.33
Q04 2017--0.23-
Q03 2017-0.23-0.25-8.70
Q02 2017-0.09-0.0188.89
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.330.00-
12/2018 QR-0.32-45.45Negative
12/2019 FY-1.550.00-
12/2020 FY-0.880.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume11.37M
Shares Outstanding74.57M
Trades Count9.29K
Dollar Volume3.42M
Avg. Volume2.59M
Avg. Weekly Volume26.75M
Avg. Monthly Volume9.57M
Avg. Quarterly Volume3.76M

INSYS Therapeutics, Inc. (NASDAQ: INSY) stock closed at 0.29 per share at the end of the most recent trading day (a -1.36% change compared to the prior day closing price) with a volume of 11.37M shares and market capitalization of 21.63M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs people. INSYS Therapeutics, Inc. CEO is .

The one-year performance of INSYS Therapeutics, Inc. stock is -96.25%, while year-to-date (YTD) performance is 0%. INSY stock has a five-year performance of -99.21%. Its 52-week range is between 0.14 and 11.65, which gives INSY stock a 52-week price range ratio of %

INSYS Therapeutics, Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -%, a ROC of -% and a ROE of -%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $- revenue per share.

Of the last four earnings reports from INSYS Therapeutics, Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. INSYS Therapeutics, Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for INSYS Therapeutics, Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for INSYS Therapeutics, Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

INSYS Therapeutics, Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

INSYS Therapeutics, Inc. has a technical analysis rating based on Technical Indicators (), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of INSYS Therapeutics, Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (40.00 %)
3 (60.00 %)
Moderate Buy
1 (25.00 %)
1 (20.00 %)
1 (20.00 %)
Hold
1 (25.00 %)
1 (20.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
1 (20.00 %)
1 (20.00 %)
Summary Rating---

INSYS Therapeutics, Inc.

CEO:

Teplephone:

Address: , , ,

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

42%58%

Bearish Bullish

52%48%

Bearish Bullish

61%39%

News

Stocktwits